annual cash & cash equivalents:
$2.96M+$1.40M(+89.24%)Summary
- As of today (May 29, 2025), RGC annual cash & cash equivalents is $2.96 million, with the most recent change of +$1.40 million (+89.24%) on June 1, 2024.
- During the last 3 years, RGC annual cash & cash equivalents has risen by +$2.90 million (+4885.19%).
- RGC annual cash & cash equivalents is now -53.85% below its all-time high of $6.42 million, reached on June 30, 2022.
Performance
RGC Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.96M(NaN%)Summary
- As of today (May 29, 2025), RGC quarterly cash & cash equivalents is $2.96 million
- Over the past year, RGC quarterly cash & cash equivalents has increased by +$1.40 million (+89.24%).
- RGC quarterly cash & cash equivalents is now -53.85% below its all-time high of $6.42 million, reached on June 30, 2022.
Performance
RGC quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RGC Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +89.2% | +89.2% |
| 3 y3 years | +4885.2% | +4885.2% |
| 5 y5 years | +1117.1% | +665.2% |
RGC Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.9% | +4885.2% | -53.9% | +89.2% |
| 5 y | 5-year | -53.9% | +4885.2% | -53.9% | +4885.2% |
| alltime | all time | -53.9% | +4885.2% | -53.9% | +4885.2% |
RGC Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | $2.96M(+89.2%) | $2.96M(+89.2%) |
| Jun 2023 | $1.56M(-75.6%) | $1.56M(-75.6%) |
| Jun 2022 | $6.42M(>+9900.0%) | $6.42M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | $59.40K(-84.7%) | $59.40K(-80.6%) |
| Dec 2020 | - | $306.00K(-20.9%) |
| Jun 2020 | $387.00K(+59.1%) | $387.00K |
| Jun 2019 | $243.30K | - |
FAQ
- What is Regencell Bioscience Holdings Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Regencell Bioscience Holdings Limited?
- What is Regencell Bioscience Holdings Limited annual cash & cash equivalents year-on-year change?
- What is Regencell Bioscience Holdings Limited quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Regencell Bioscience Holdings Limited?
- What is Regencell Bioscience Holdings Limited quarterly cash & cash equivalents year-on-year change?
What is Regencell Bioscience Holdings Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of RGC is $2.96M
What is the all time high annual cash & cash equivalents for Regencell Bioscience Holdings Limited?
Regencell Bioscience Holdings Limited all-time high annual cash & cash equivalents is $6.42M
What is Regencell Bioscience Holdings Limited annual cash & cash equivalents year-on-year change?
Over the past year, RGC annual cash & cash equivalents has changed by +$1.40M (+89.24%)
What is Regencell Bioscience Holdings Limited quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RGC is $2.96M
What is the all time high quarterly cash & cash equivalents for Regencell Bioscience Holdings Limited?
Regencell Bioscience Holdings Limited all-time high quarterly cash & cash equivalents is $6.42M
What is Regencell Bioscience Holdings Limited quarterly cash & cash equivalents year-on-year change?
Over the past year, RGC quarterly cash & cash equivalents has changed by +$1.40M (+89.24%)